Actualités Cipher Pharmaceuticals Inc - CPH | Actions Toronto Stock Exchange

Cipher Pharmaceuticals Reports 2015 Financial Results

Cipher Pharmaceuticals Reports 2015 Financial Results PR Newswire MISSISSAUGA, ON, Feb. 24, 2016 Q4 revenue up 30%, Company significantly...

Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerall™

Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerall™ PR Newswire MISSISSAUGA, ON, Feb. 22, 2016 MISSISSAUGA, ON, Feb. 22...

Cipher Pharmaceuticals Launches a Foam Preparation of Bionect

- Offers Dermatologists a New Formulation of Leading Topical Product with Low Molecular Weight Hyaluronic Acid - - Bionect® Foam Improves...

Cipher Pharmaceuticals Inc. announces Sitavig™ accepted for review by Health Canada

Cipher Pharmaceuticals Inc. announces Sitavig™ accepted for review by Health Canada PR Newswire MISSISSAUGA, ON, Feb. 16, 2016 MISSISSAUGA...

Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call

Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call PR Newswire MISSISSAUGA, ON, Feb. 9, 2016 MISSISSAUGA, ON, Feb. 9...

Cipher Receives Health Canada Approval of (Pr)Beteflam™

Cipher Receives Health Canada Approval of (Pr)Beteflam™ PR Newswire MISSISSAUGA, ON, Dec. 7, 2015 – Will Represent Fourth Commercial...

Cipher Pharmaceuticals to present at Piper Jaffray Healthcare Conference 2015

Cipher Pharmaceuticals to present at Piper Jaffray Healthcare Conference 2015 PR Newswire MISSISSAUGA, ON, Nov. 25, 2015 MISSISSAUGA, ON, Nov...

Cipher Reports Third Quarter Results

Cipher Reports Third Quarter Results PR Newswire MISSISSAUGA, ON, Nov. 4, 2015 – Quarter Highlighted by 28% Revenue Growth, $2.3 Million in Cash...

Cipher announces settlement in patent litigation for Absorica®

Cipher announces settlement in patent litigation for Absorica® PR Newswire MISSISSAUGA, ON, Oct. 5, 2015 MISSISSAUGA, ON, Oct. 5, 2015...

Cipher Pharmaceuticals announces acceptance of 510(k) submission for Dermadexin™ by FDA

Cipher Pharmaceuticals announces acceptance of 510(k) submission for Dermadexin™ by FDA PR Newswire MISSISSAUGA, ON, Aug. 4, 2015...

Cipher Pharmaceuticals to Present at 2015 JMP Securities Life Sciences Conference

Cipher Pharmaceuticals to Present at 2015 JMP Securities Life Sciences Conference PR Newswire MISSISSAUGA, ON, June 19, 2015 MISSISSAUGA, ON...

Cipher Pharmaceuticals to Present at BIO International Convention

Cipher Pharmaceuticals to Present at BIO International Convention PR Newswire MISSISSAUGA, ON, June 4, 2015 MISSISSAUGA, ON, June 4, 2015...

Cipher Pharmaceuticals Strengthens Leadership Team with Key Executive Appointments and Announces Launch of Vaniqa® in Canada

Cipher Pharmaceuticals Strengthens Leadership Team with Key Executive Appointments and Announces Launch of Vaniqa® in Canada PR...

Cipher Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference

Cipher Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference PR Newswire MISSISSAUGA, ON, May 28, 2015 MISSISSAUGA, ON, May...

Cipher Reports Financial and Operational Results for Q1 2015

Cipher Reports Financial and Operational Results for Q1 2015 PR Newswire MISSISSAUGA, ON, May 13, 2015 – Company Achieves Significant Progress...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cipher Pharmaceuticals Inc (CPH)

Votre Hub pour des idées et discussions en direct en temps réel

CPH Actualités

Cipher Pharmaceuticals Reports 2015 Financial Results

Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerall™

Cipher Pharmaceuticals Launches a Foam Preparation of Bionect

Cipher Pharmaceuticals Inc. announces Sitavig™ accepted for review by Health Canada

Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call

Cipher Receives Health Canada Approval of (Pr)Beteflam™

Cipher Pharmaceuticals to present at Piper Jaffray Healthcare Conference 2015

Cipher Reports Third Quarter Results

Cipher announces settlement in patent litigation for Absorica®

Cipher Pharmaceuticals announces acceptance of 510(k) submission for Dermadexin™ by FDA

Cipher Pharmaceuticals to Present at 2015 JMP Securities Life Sciences Conference

Cipher Pharmaceuticals to Present at BIO International Convention

Cipher Pharmaceuticals Strengthens Leadership Team with Key Executive Appointments and Announces Launch of Vaniqa® in Canada

Cipher Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference

Cipher Reports Financial and Operational Results for Q1 2015

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cipher Pharmaceuticals Inc (CPH) Actualités

Cipher Pharmaceuticals Inc (CPH)

Votre Hub pour des idées et discussions en direct en temps réel

CPH Actualités

Cipher Pharmaceuticals Reports 2015 Financial Results

Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerall™

Cipher Pharmaceuticals Launches a Foam Preparation of Bionect

Cipher Pharmaceuticals Inc. announces Sitavig™ accepted for review by Health Canada

Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call

Cipher Receives Health Canada Approval of (Pr)Beteflam™

Cipher Pharmaceuticals to present at Piper Jaffray Healthcare Conference 2015

Cipher Reports Third Quarter Results

Cipher announces settlement in patent litigation for Absorica®

Cipher Pharmaceuticals announces acceptance of 510(k) submission for Dermadexin™ by FDA

Cipher Pharmaceuticals to Present at 2015 JMP Securities Life Sciences Conference

Cipher Pharmaceuticals to Present at BIO International Convention

Cipher Pharmaceuticals Strengthens Leadership Team with Key Executive Appointments and Announces Launch of Vaniqa® in Canada

Cipher Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference

Cipher Reports Financial and Operational Results for Q1 2015

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application